TABLE 1 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 2 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 3 GLOBAL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 4 GLOBAL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 5 GLOBAL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 6 GLOBAL INSTRUMENTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 7 GLOBAL SOFTWARE AND SERVICES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 8 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 9 GLOBAL WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 10 GLOBAL WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 11 GLOBAL EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 GLOBAL KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 13 GLOBAL LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 GLOBAL DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 GLOBAL MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 GLOBAL CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 GLOBAL CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 GLOBAL ANXIETY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 GLOBAL DEPRESSION IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 GLOBAL MOOD DISORDERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 GLOBAL BIPOLAR DISORDERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 GLOBAL EATING DISORDERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 GLOBAL PSYCHOTIC DISORDERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 26 GLOBAL CYP2C19 IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 GLOBAL CYP2C9 AND VKORC1 IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 GLOBAL CYP2D6 IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 GLOBAL HLA-B IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 GLOBAL HTR2A/C IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 GLOBAL HLA-A IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 GLOBAL CYP3A4 IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 GLOBAL SLC6A4 IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 GLOBAL MTHFR IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 GLOBAL COMT IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 GLOBAL OTHERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 37 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 GLOBAL ADULT IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 39 GLOBAL GERIATRIC IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 GLOBAL CHILD IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 42 GLOBAL HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 43 GLOBAL HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 44 GLOBAL DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 45 GLOBAL DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 46 GLOBAL ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 GLOBAL ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 48 GLOBAL OTHERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 49 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 50 GLOBAL DIRECT TENDER IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 GLOBAL THIRD PARTY DISTRIBUTION IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 52 GLOBAL HOSPITAL PHARMACY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 GLOBAL OTHERS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 55 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 56 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 58 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 59 NORTH AMERICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 60 NORTH AMERICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 61 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 NORTH AMERICA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 NORTH AMERICA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 64 NORTH AMERICA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 65 NORTH AMERICA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 NORTH AMERICA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 67 NORTH AMERICA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 NORTH AMERICA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 72 NORTH AMERICA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 73 NORTH AMERICA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 74 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 75 NORTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 76 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 78 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 79 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 80 U.S. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 81 U.S. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 82 U.S. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 83 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 U.S. WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 U.S. EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 U.S. KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 U.S. LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 U.S. DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 U.S. MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 90 U.S. CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 91 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 94 U.S. HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 95 U.S. DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 96 U.S. ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 97 U.S. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 98 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 100 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 101 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 102 CANADA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 103 CANADA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 104 CANADA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 105 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 CANADA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 CANADA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 CANADA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 CANADA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 CANADA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 CANADA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 112 CANADA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 116 CANADA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 117 CANADA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 118 CANADA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 119 CANADA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 120 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 122 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 123 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 124 MEXICO CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 125 MEXICO CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 126 MEXICO CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 127 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 MEXICO WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 MEXICO EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 MEXICO KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 MEXICO LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 MEXICO DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 133 MEXICO MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 MEXICO CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 136 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 138 MEXICO HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 139 MEXICO DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 140 MEXICO ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 141 MEXICO PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 142 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 143 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 145 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 146 EUROPE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 147 EUROPE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 148 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 EUROPE WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 EUROPE EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 151 EUROPE KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 EUROPE LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 153 EUROPE DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 EUROPE MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 EUROPE CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 159 EUROPE HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 160 EUROPE DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 161 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 162 EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 163 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 164 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 165 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 166 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 167 GERMANY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 168 GERMANY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 169 GERMANY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 170 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 GERMANY WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 172 GERMANY EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 173 GERMANY KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 174 GERMANY LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 GERMANY DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 176 GERMANY MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 GERMANY CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 181 GERMANY HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 182 GERMANY DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 183 GERMANY ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 184 GERMANY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 185 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 187 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 188 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 189 FRANCE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 190 FRANCE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 191 FRANCE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 192 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 193 FRANCE WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 194 FRANCE EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 FRANCE KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 196 FRANCE LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 FRANCE DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 FRANCE MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 FRANCE CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 203 FRANCE HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 204 FRANCE DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 205 FRANCE ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 206 FRANCE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 207 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 209 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 210 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 211 U.K. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 212 U.K. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 213 U.K. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 214 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 U.K. WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 216 U.K. EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 U.K. KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 218 U.K. LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 U.K. DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 U.K. MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 221 U.K. CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 223 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 224 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 225 U.K. HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 226 U.K. DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 227 U.K. ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 228 U.K. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 229 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 230 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 231 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 232 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 233 ITALY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 234 ITALY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 235 ITALY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 236 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 237 ITALY WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 238 ITALY EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 239 ITALY KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 ITALY LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 241 ITALY DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 242 ITALY MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 243 ITALY CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 244 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 245 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 246 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 247 ITALY HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 248 ITALY DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 249 ITALY ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 250 ITALY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 251 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 252 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 253 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 254 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 255 RUSSIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 256 RUSSIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 257 RUSSIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 258 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 259 RUSSIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 260 RUSSIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 261 RUSSIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 262 RUSSIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 263 RUSSIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 264 RUSSIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 265 RUSSIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 266 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 267 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 269 RUSSIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 270 RUSSIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 271 RUSSIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 272 RUSSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 273 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 274 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 275 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 276 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 277 SPAIN CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 278 SPAIN CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 279 SPAIN CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 280 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 281 SPAIN WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 SPAIN EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 283 SPAIN KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 284 SPAIN LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 285 SPAIN DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 286 SPAIN MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 287 SPAIN CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 289 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 290 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 291 SPAIN HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 292 SPAIN DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 293 SPAIN ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 294 SPAIN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 295 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 296 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 297 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 298 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 299 TURKEY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 300 TURKEY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 301 TURKEY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 302 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 303 TURKEY WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 304 TURKEY EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 305 TURKEY KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 306 TURKEY LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 307 TURKEY DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 308 TURKEY MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 309 TURKEY CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 310 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 311 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 312 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 313 TURKEY HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 314 TURKEY DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 315 TURKEY ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 316 TURKEY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 317 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 318 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 319 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 320 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 321 NETHERLANDS CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 322 NETHERLANDS CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 323 NETHERLANDS CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 324 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 325 NETHERLANDS WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 326 NETHERLANDS EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 327 NETHERLANDS KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 328 NETHERLANDS LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 329 NETHERLANDS DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 330 NETHERLANDS MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 331 NETHERLANDS CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 332 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 333 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 334 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 335 NETHERLANDS HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 336 NETHERLANDS DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 337 NETHERLANDS ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 338 NETHERLANDS PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 339 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 341 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 342 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 343 SWITZERLAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 344 SWITZERLAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 345 SWITZERLAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 346 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 347 SWITZERLAND WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 348 SWITZERLAND EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 349 SWITZERLAND KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 350 SWITZERLAND LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 351 SWITZERLAND DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 352 SWITZERLAND MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 353 SWITZERLAND CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 354 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 355 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 356 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 357 SWITZERLAND HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 358 SWITZERLAND DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 359 SWITZERLAND ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 360 SWITZERLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 361 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 362 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 363 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 364 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 365 POLAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 366 POLAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 367 POLAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 368 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 369 POLAND WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 370 POLAND EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 371 POLAND KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 372 POLAND LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 373 POLAND DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 374 POLAND MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 375 POLAND CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 376 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 377 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 378 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 379 POLAND HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 380 POLAND DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 381 POLAND ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 382 POLAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 383 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 384 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 385 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 386 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 387 HUNGARY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 388 HUNGARY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 389 HUNGARY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 390 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 391 HUNGARY WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 392 HUNGARY EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 393 HUNGARY KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 394 HUNGARY LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 395 HUNGARY DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 396 HUNGARY MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 397 HUNGARY CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 398 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 399 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 400 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 401 HUNGARY HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 402 HUNGARY DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 403 HUNGARY ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 404 HUNGARY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 405 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 406 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 407 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 408 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 409 AUSTRIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 410 AUSTRIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 411 AUSTRIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 412 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 413 AUSTRIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 414 AUSTRIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 415 AUSTRIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 416 AUSTRIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 417 AUSTRIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 418 AUSTRIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 419 AUSTRIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 420 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 421 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 422 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 423 AUSTRIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 424 AUSTRIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 425 AUSTRIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 426 AUSTRIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 427 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 428 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 429 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 430 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 431 NORWAY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 432 NORWAY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 433 NORWAY CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 434 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 435 NORWAY WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 436 NORWAY EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 437 NORWAY KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 438 NORWAY LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 439 NORWAY DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 440 NORWAY MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 441 NORWAY CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 442 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 443 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 444 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 445 NORWAY HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 446 NORWAY DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 447 NORWAY ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 448 NORWAY PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 449 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 450 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 451 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 452 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 453 IRELAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 454 IRELAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 455 IRELAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 456 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 457 IRELAND WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 458 IRELAND EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 459 IRELAND KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 460 IRELAND LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 461 IRELAND DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 462 IRELAND MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 463 IRELAND CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 464 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 465 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 466 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 467 IRELAND HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 468 IRELAND DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 469 IRELAND ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 470 IRELAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 471 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 472 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 473 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 474 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 475 LITHUANIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 476 LITHUANIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 477 LITHUANIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 478 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 479 LITHUANIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 480 LITHUANIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 481 LITHUANIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 482 LITHUANIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 483 LITHUANIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 484 LITHUANIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 485 LITHUANIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 486 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 487 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 488 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 489 LITHUANIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 490 LITHUANIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 491 LITHUANIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 492 LITHUANIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 493 REST OF EUROPE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 494 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 495 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 496 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 497 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 498 ASIA-PACIFIC CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 499 ASIA-PACIFIC CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 500 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 501 ASIA-PACIFIC WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 502 ASIA-PACIFIC EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 503 ASIA-PACIFIC KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 504 ASIA-PACIFIC LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 505 ASIA-PACIFIC DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 506 ASIA-PACIFIC MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 507 ASIA-PACIFIC CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 508 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 509 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 510 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 511 ASIA-PACIFIC HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 512 ASIA-PACIFIC DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 513 ASIA-PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 514 ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 515 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 516 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 517 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 518 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 519 JAPAN CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 520 JAPAN CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 521 JAPAN CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 522 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 523 JAPAN WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 524 JAPAN EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 525 JAPAN DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 526 JAPAN MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 527 JAPAN CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 528 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 529 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 530 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 531 JAPAN HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 532 JAPAN DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 533 JAPAN ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 534 JAPAN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 535 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 536 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 537 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 538 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 539 CHINA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 540 CHINA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 541 CHINA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 542 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 543 CHINA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 544 CHINA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 545 CHINA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 546 CHINA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 547 CHINA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 548 CHINA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 549 CHINA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 550 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 551 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 552 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 553 CHINA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 554 CHINA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 555 CHINA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 556 CHINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 557 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 558 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 559 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 560 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 561 SOUTH KOREA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 562 SOUTH KOREA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 563 SOUTH KOREA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 564 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 565 SOUTH KOREA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 566 SOUTH KOREA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 567 SOUTH KOREA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 568 SOUTH KOREA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 569 SOUTH KOREA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 570 SOUTH KOREA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 571 SOUTH KOREA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 572 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 573 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 574 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 575 SOUTH KOREA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 576 SOUTH KOREA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 577 SOUTH KOREA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 578 SOUTH KOREA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 579 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 580 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 581 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 582 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 583 INDIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 584 INDIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 585 INDIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 586 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 587 INDIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 588 INDIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 589 INDIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 590 INDIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 591 INDIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 592 INDIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 593 INDIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 594 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 595 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 596 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 597 INDIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 598 INDIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 599 INDIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 600 INDIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 601 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 602 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 603 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 604 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 605 AUSTRALIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 606 AUSTRALIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 607 AUSTRALIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 608 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 609 AUSTRALIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 610 AUSTRALIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 611 AUSTRALIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 612 AUSTRALIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 613 AUSTRALIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 614 AUSTRALIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 615 AUSTRALIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 616 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 617 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 618 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 619 AUSTRALIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 620 AUSTRALIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 621 AUSTRALIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 622 AUSTRALIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 623 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 624 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 625 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 626 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 627 SINGAPORE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 628 SINGAPORE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 629 SINGAPORE CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 630 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 631 SINGAPORE WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 632 SINGAPORE EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 633 SINGAPORE KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 634 SINGAPORE LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 635 SINGAPORE DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 636 SINGAPORE MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 637 SINGAPORE CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 638 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 639 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 640 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 641 SINGAPORE HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 642 SINGAPORE DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 643 SINGAPORE ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 644 SINGAPORE PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 645 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 646 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 647 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 648 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 649 THAILAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 650 THAILAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 651 THAILAND CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 652 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 653 THAILAND WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 654 THAILAND EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 655 THAILAND KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 656 THAILAND LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 657 THAILAND DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 658 THAILAND MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 659 THAILAND CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 660 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 661 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 662 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 663 THAILAND HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 664 THAILAND DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 665 THAILAND ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 666 THAILAND PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 667 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 668 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 669 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 670 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 671 MALAYSIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 672 MALAYSIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 673 MALAYSIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 674 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 675 MALAYSIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 676 MALAYSIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 677 MALAYSIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 678 MALAYSIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 679 MALAYSIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 680 MALAYSIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 681 MALAYSIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 682 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 683 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 684 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 685 MALAYSIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 686 MALAYSIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 687 MALAYSIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 688 MALAYSIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 689 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 690 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 691 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 692 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 693 INDONESIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 694 INDONESIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 695 INDONESIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 696 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 697 INDONESIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 698 INDONESIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 699 INDONESIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 700 INDONESIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 701 INDONESIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 702 INDONESIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 703 INDONESIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 704 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 705 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 706 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 707 INDONESIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 708 INDONESIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 709 INDONESIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 710 INDONESIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 711 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 712 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 713 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 714 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 715 PHILIPPINES CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 716 PHILIPPINES CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 717 PHILIPPINES CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 718 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 719 PHILIPPINES WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 720 PHILIPPINES EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 721 PHILIPPINES KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 722 PHILIPPINES LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 723 PHILIPPINES DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 724 PHILIPPINES MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 725 PHILIPPINES CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 726 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 727 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 728 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 729 PHILIPPINES HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 730 PHILIPPINES DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 731 PHILIPPINES ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 732 PHILIPPINES PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 733 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 734 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 735 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 736 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 737 VIETNAM CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 738 VIETNAM CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME, (UNITS)
TABLE 739 VIETNAM CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 740 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 741 VIETNAM WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 742 VIETNAM EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 743 VIETNAM KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 744 VIETNAM LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 745 VIETNAM DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 746 VIETNAM MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 747 VIETNAM CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 748 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 749 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 750 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 751 VIETNAM HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 752 VIETNAM DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 753 VIETNAM ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 754 VIETNAM PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 755 REST OF ASIA-PACIFIC PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 756 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 757 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 758 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 759 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 760 MIDDLE EAST AND AFRICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 761 MIDDLE EAST AND AFRICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 762 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 763 MIDDLE EAST AND AFRICA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 764 MIDDLE EAST AND AFRICA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 765 MIDDLE EAST AND AFRICA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 766 MIDDLE EAST AND AFRICA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 767 MIDDLE EAST AND AFRICA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 768 MIDDLE EAST AND AFRICA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 769 MIDDLE EAST AND AFRICA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 770 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 771 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 772 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 773 MIDDLE EAST AND AFRICA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 774 MIDDLE EAST AND AFRICA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 775 MIDDLE EAST AND AFRICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 776 MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 777 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 778 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 779 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 780 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 781 SOUTH AFRICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 782 SOUTH AFRICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 783 SOUTH AFRICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 784 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 785 SOUTH AFRICA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 786 SOUTH AFRICA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 787 SOUTH AFRICA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 788 SOUTH AFRICA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 789 SOUTH AFRICA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 790 SOUTH AFRICA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 791 SOUTH AFRICA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 792 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 793 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 794 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 795 SOUTH AFRICA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 796 SOUTH AFRICA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 797 SOUTH AFRICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 798 SOUTH AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 799 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 800 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 801 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 802 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 803 SAUDI ARABIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 804 SAUDI ARABIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 805 SAUDI ARABIA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 806 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 807 SAUDI ARABIA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 808 SAUDI ARABIA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 809 SAUDI ARABIA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 810 SAUDI ARABIA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 811 SAUDI ARABIA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 812 SAUDI ARABIA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 813 SAUDI ARABIA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 814 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 815 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 816 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 817 SAUDI ARABIA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 818 SAUDI ARABIA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 819 SAUDI ARABIA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 820 SAUDI ARABIA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 821 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 822 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 823 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 824 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 825 U.A.E. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 826 U.A.E. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 827 U.A.E. CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 828 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 829 U.A.E. WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 830 U.A.E. EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 831 U.A.E. KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 832 U.A.E. LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 833 U.A.E. DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 834 U.A.E. MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 835 U.A.E. CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 836 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 837 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 838 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 839 U.A.E. HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 840 U.A.E. DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 841 U.A.E. ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 842 U.A.E. PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 843 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 844 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 845 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 846 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 847 ISRAEL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 848 ISRAEL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 849 ISRAEL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 850 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 851 ISRAEL WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 852 ISRAEL EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 853 ISRAEL KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 854 ISRAEL LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 855 ISRAEL DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 856 ISRAEL MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 857 ISRAEL CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 858 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 859 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 860 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 861 ISRAEL HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 862 ISRAEL DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 863 ISRAEL ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 864 ISRAEL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 865 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 866 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 867 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 868 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 869 EGYPT CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 870 EGYPT CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 871 EGYPT CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 872 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 873 EGYPT WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 874 EGYPT EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 875 EGYPT KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 876 EGYPT LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 877 EGYPT DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 878 EGYPT MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 879 EGYPT CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 880 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 881 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 882 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 883 EGYPT HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 884 EGYPT DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 885 EGYPT ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 886 EGYPT PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 887 REST OF MIDDLE EAST AND AFRICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 888 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 889 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 890 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 891 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 892 SOUTH AMERICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 893 SOUTH AMERICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 894 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 895 SOUTH AMERICA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 896 SOUTH AMERICA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 897 SOUTH AMERICA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 898 SOUTH AMERICA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 899 SOUTH AMERICA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 900 SOUTH AMERICA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 901 SOUTH AMERICA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 902 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 903 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 904 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 905 SOUTH AMERICA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 906 SOUTH AMERICA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 907 SOUTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 908 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 909 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 910 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 911 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 912 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 913 BRAZIL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 914 BRAZIL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 915 BRAZIL CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 916 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 917 BRAZIL WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 918 BRAZIL EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 919 BRAZIL KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 920 BRAZIL LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 921 BRAZIL DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 922 BRAZIL MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 923 BRAZIL CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 924 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 925 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 926 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 927 BRAZIL HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 928 BRAZIL DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 929 BRAZIL ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 930 BRAZIL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 931 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 932 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 933 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 934 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 935 ARGENTINA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 936 ARGENTINA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 937 ARGENTINA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 938 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 939 ARGENTINA WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 940 ARGENTINA EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 941 ARGENTINA KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 942 ARGENTINA LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 943 ARGENTINA DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 944 ARGENTINA MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 945 ARGENTINA CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 946 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 947 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 948 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 949 ARGENTINA HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 950 ARGENTINA DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 951 ARGENTINA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 952 ARGENTINA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 953 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 954 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 955 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 956 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 957 PERU CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 958 PERU CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 959 PERU CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 ASP (USD)
TABLE 960 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 961 PERU WHOLE GENOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 962 PERU EXOME SEQUENCING IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 963 PERU KARYOTYPE IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 964 PERU LOW COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 965 PERU DEEP COVERAGE WGS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 966 PERU MICROARRAY IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 967 PERU CHROMOSOMAL ARRAY BASED TESTS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 968 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, GENE TYPE, 2022-2031 (USD THOUSAND)
TABLE 969 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 970 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 971 PERU HOSPITAL AND CLINICS IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 972 PERU DIAGNOSTICS LABORATORIES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 973 PERU ACADEMIC AND RESEARCH INSTITUTES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 974 PERU PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 975 REST OF SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 976 SOUTH AMERICA PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 VOLUME (UNITS)
TABLE 977 SOUTH AMERICA CONSUMABLES IN PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)